The European Commission granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Bracco-EU-Autho

More Like This

PR Newswire associated0

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion

PR Newswire associated0

Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union

A radiologist looking at MRI exam images (Photo: Business Wire)

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

PR Newswire associated0

Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

PR Newswire associated0

Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars

Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars

European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD